Dermatology Research and Practice (Jan 2012)

Differential Downregulation of E-Cadherin and Desmoglein by Epidermal Growth Factor

  • Miquella G. Chavez,
  • Christian A. Buhr,
  • Whitney K. Petrie,
  • Angela Wandinger-Ness,
  • Donna F. Kusewitt,
  • Laurie G. Hudson

DOI
https://doi.org/10.1155/2012/309587
Journal volume & issue
Vol. 2012

Abstract

Read online

Modulation of cell : cell junctions is a key event in cutaneous wound repair. In this study we report that activation of the epidermal growth factor (EGF) receptor disrupts cel : cell adhesion, but with different kinetics and fates for the desmosomal cadherin desmoglein and for E-cadherin. Downregulation of desmoglein preceded that of E-cadherin in vivo and in an EGF-stimulated in vitro wound reepithelialization model. Dual immunofluorescence staining revealed that neither E-cadherin nor desmoglein-2 internalized with the EGF receptor, or with one another. In response to EGF, desmoglein-2 entered a recycling compartment based on predominant colocalization with the recycling marker Rab11. In contrast, E-cadherin downregulation was accompanied by cleavage of the extracellular domain. A broad-spectrum matrix metalloproteinase inhibitor protected E-cadherin but not the desmosomal cadherin, desmoglein-2, from EGF-stimulated disruption. These findings demonstrate that although activation of the EGF receptor regulates adherens junction and desmosomal components, this stimulus downregulates associated cadherins through different mechanisms.